Atlas Trials

Refractory Mycosis Fungoides and Sezary Syndrome

3 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Refractory Mycosis Fungoides and Sezary Syndrome

RecordFirmDate
Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment (NCT04541017)National Cancer Institute (NCI)2021-04-06
Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma (NCT03063632)National Cancer Institute (NCI)2017-12-14
Pembrolizumab in Treating Patients With Relapsed or Refractory Stage IB-IVB Mycosis Fungoides or Sezary Syndrome (NCT02243579)National Cancer Institute (NCI)2014-10-15

Track Refractory Mycosis Fungoides and Sezary Syndrome automatically

Every clearance here is in the API, with alerts when new ones post.